AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glitaray M 3mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glitaray M 3mg/500mg Tablet PR

Diabex Duo 3mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Diabex Duo is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are essential for effective diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is vital. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glitaray M 3mg/500mg Tablet PR

No information provided. Please provide the text you wish me to rephrase.

Uses of Glitaray M 3mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Glitaray M 3mg/500mg Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Consume Glitaray M 3mg/500mg Tablet PR with a meal.

Common Side effects of Glitaray M 3mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glitaray M 3mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage information. Administer Glitaray M 3mg/500mg Tablet PR with a meal.

How Glitaray M 3mg/500mg Tablet PR works:

Glitaray M 3mg/500mg tablets are a dual-action antidiabetic formulation comprising glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glitaray M 3mg/500mg Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glitaray M 3mg/500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against the risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glitaray M 3mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glitaray M 3mg/500mg Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glitaray M 3mg/500mg Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glitaray M 3mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glitaray M 3mg/500mg Tablet PR :

Should you forget a dose of Glitaray M 3mg/500mg Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glitaray M 3mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glitaray M 3mg/500mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glitaray M 3mg/500mg Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glitaray M 3mg/500mg Tablet PR and seek immediate medical attention.
Glitaray M 3mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glitaray M 3mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glitaray M 3mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glitaray M 3mg/500mg Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glitaray M 3mg/500mg Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glitaray M 3mg/500mg Tabl...
172
MRP 199
13% off